Q3 2024 Holdings
Filed 2024-11-14 | 59 holdings | $147.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-12-13) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $9.3M | 10,447 | 6.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.5M | 43,849 | 4.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.4M | 211,000 | 3.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $5.3M | 120,165 | 3.6% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $4.9M | 207,627 | 3.3% |
| Align Technology Inc(ALGN) | COM | 016255101 | $4.8M | 18,700 | 3.2% |
| The Cigna Group(CI) | COM | 125523100 | $4.2M | 12,200 | 2.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $4.2M | 50,000 | 2.8% |
| Geron Corp(GERN) | COM | 374163103 | $4.1M | 905,126 | 2.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $4.1M | 34,552 | 2.8% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $4.0M | 78,000 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.0M | 174,400 | 2.7% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $3.6M | 7,427 | 2.5% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.4M | 15,300 | 2.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $3.4M | 36,700 | 2.3% |
| Glaukos Corp(GKOS) | COM | 377322102 | $3.4M | 25,857 | 2.3% |
| Springworks Therapeutics Inc | COM | 85205L107 | $3.2M | 100,700 | 2.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $3.2M | 64,516 | 2.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.1M | 58,583 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.9M | 66,200 | 2.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $2.9M | 414,629 | 2.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.9M | 100,367 | 2.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $2.9M | 36,300 | 1.9% |
| Natera Inc(NTRA) | COM | 632307104 | $2.9M | 22,450 | 1.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.6M | 13,317 | 1.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.5M | 33,600 | 1.7% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $2.3M | 47,000 | 1.5% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.2M | 1,178,570 | 1.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $2.2M | 300,600 | 1.5% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $2.2M | 77,100 | 1.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $2.2M | 138,152 | 1.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.2M | 176,600 | 1.5% |
| Amgen Inc(AMGN) | COM | 031162100 | $2.2M | 6,700 | 1.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.1M | 89,800 | 1.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $2.0M | 19,945 | 1.4% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $1.8M | 347,600 | 1.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.8M | 90,305 | 1.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $1.7M | 352,056 | 1.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $1.7M | 149,600 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $1.6M | 59,900 | 1.1% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $1.5M | 2,000,000 | 1.0% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $1.5M | 40,800 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.5M | 45,600 | 1.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.5M | 196,500 | 1.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.1M | 133,039 | 0.8% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $1.1M | 36,344 | 0.7% |
| Alvotech(ALVO)A | ORDINARY SHARES | L01800108 | $1.1M | 90,100 | 0.7% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $952.6K | 73,501 | 0.6% |
| Establishment Labs Hldgs Inc(ESTA)A | COM | G31249108 | $939.0K | 21,700 | 0.6% |
| Acrivon Therapeutics Inc(ACRV) | COMMON STOCK | 004890109 | $817.3K | 116,757 | 0.6% |